Abstract
The availability of platelet transfusion support to patients with bone marrow failure (such as aplastic anemia, or malignancy undergoing chemotherapy), has reduced the incidence of hemorrhage. However, infection then became the major cause of death in these patients [1]. There is an inverse relationship between the granulocyte count and the percent of days patients spend with infections [2]. Early studies showed that patients were at an increased risk of infection when the granulocyte count fell below 1000/µl [2]; although more recent data indicates that serious infection is not a problem until the granulocyte count falls below 500/µl [3]. One approach to the management of infection in patients with bone marrow failure is to replace depleted granulocyte stores by giving granulocyte transfusions. Because of the relatively small number of granulocytes in the circulation of normal people, early experience with granulocyte transfusions involved the use of patients with chronic myelogenous leukemia (CML) as donors [4]. Using large doses of granulocytes, increments in peripheral blood granulocyte count were observed and clinical improvement in the patients occurred a few hours following transfusion. Usually only one or two transfusions were necessary. During the early 1970’s there were many reports describing patients who improved following granulocyte transfusion. The reports concluded that granulocyte transfusions were useful, as evidenced by: a) clinical improvement following transfusions, often in patients previously unresponsive to antibiotics, and b) appearance of granulocytes in sites of infection which did not have an inflammatory response prior to transfusion. Because of this, there was great interest in making granulocyte transfusions widely available for use in treating granulocytopenic patients. This chapter will describe the methods presently available for granulocyte collection, the function of the cells collected and approaches to evaluating the effectiveness of the transfusions. The latter is especially important because as blood cell separators became available during the 1970’s, the source of granulocytes shifted from CML patients to normal donors. As a result, the dose of granulocytes transfused fell to approximately 10% of that used in earlier studies, and it became increasingly difficult to achieve obvious clinical benefits from a single transfusion [5]. Before considering granulocyte collection, it is appropriate to briefly review granulocyte production.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hersh EM, Bodey GP, Nies BA, Freireich EJ: Causes of death in acute leukemia. A ten-year study of 414 patients from 1954 to 1963. JAMA, 1965; 193: 105–9.
Bodey GP, Buckley M, Sathe YS, Freireich EJ: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med, 1966; 64: 328–40.
Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC International Antimicrobial Therapy Project Group. J Infect Dis, 1978; 137: 14–29.
Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE: The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann NY Acad Sci, 1965; 113: 1081–89.
Graw RG, Jr, Herzig G, Perry S, Henderson ES: Normal granulocyte transfusion therapy. Treatment of septicemia due to gram-negative bacteria. N Engl J Med, 1972; 287: 367–71.
Cline MJ, The White Cell. Harvard University Press, Cambridge, Massachusetts and London, 1975.
McCullough J: Leukapheresis and granulocyte transfusion. Clinical Reviews in Clinical Science, CRC Press, Inc., April, 1979: p. 275.
Lin AT, Smith J, Haux-Porten J, Porten R, Cullis H, Buchholz D, McCullough J: Granulocyte collection for transfusion using the Fenwal CS-3000 Blood Cell Separator. Transfusion (in review).
Mishler JM: Hydroxyethyl starch as an experimental adjunct to leukocyte separation by centrifugal means: review of safety and efficacy. Transfusion, 1975; 15: 449–60.
Ring J, Seifert J, Messmer K, Brendel W: Anaphylactoid reactions due to hydroxyethyl starch infusion. Eur Surg Res, 1976; 8: 389–99.
Bode U, Deisseroth AB: Donor toxicity in granulocyte collections: Association of lichen planus with the use of hydroxyethyl starch leukapheresis. Transfusion, 1981; 21: 83–85.
Maguire LC, Strauss RG, Koepke JA, Bowman RJ, Zelenski KR, Lambert RM, Hulse JD, Atnip AK: The elimination of hydroxyethyl starch from the blood of donors experiencing single or multiple intermittent-flow centrifugation leukapheresis. Transfusion, 1981; 21: 347–53.
Hinckley ME, Huestis DW: Premedication for optimal granulocyte collection. Plasma Ther, 1981; 2: 149–52.
Blumberg N, Shah I, Katz AJ, Morse EE: Granulocyte yields using the Haemonetics 30: Effects of variations in corticosteroid regimen and donor selection. Vox Sang, 1982; 44: 225–32.
Dahlke MB, Shah SL, Sherwood WC, Shafer AW, Brownstein PK: Priapism during filtration leukapheresis. Transfusion, 1979; 19: 482–86.
Wiltbank TB, Nusbacher J, Higby J, MacPherson JL: Abdominal pain in donors during filtration leukapheresis. Transfusion, 1977; 17: 159–62.
Hammerschmidt DE, Croddock PR, McCullough J, Kronenberg RS, Dalmasso AP, Jacob HS: Complement activation and pulmonary dysfunction during nylon-fiber filtration leukapheresis. Blood, 1978; 51: 721–30.
Strauss RG, Spitzer RE, Stitzel AE, Urmson JR, Maguire LC, Koepke JA, Thompson JS: Complement changes during leukapheresis. Transfusion, 1980; 20: 32–38.
Djerassi I: Gravity leukapheresis - a new method for collection of transfusable granulocytes. Exp Hematol, 1977; 5: 139–42.
Ambinder EP, Button GR, Cheung T, Goldberg JD, Holland JF: Filtration versus gravity leukapheresis in febrile granulocytopenic patients: A randomized prospective trial. Blood, 1981; 57: 836–41.
Aisner J, Schiffer CA, Daly PA, Buchholz DH: Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresis. Transfusion, 1981; 21: 100–5.
Glasser L: Functional considerations of granulocyte concentrates used for clinical transfusions. Transfusion, 1979; 19: 1–6.
Strauss RG, Maguire LC, Koepke JA, Thompson JS: Properties of neutrophils collected by discontinuous-flow centrifugation leukapheresis employing hydroxyethyl starch. Transfusion, 1979; 19: 192–96.
McCullough J, Weiblen BJ, Deinard AS, Boen J, Fortuny IE, Quie PG: In vitro function and post-transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis. Blood, 1976; 48: 315–326.
Appelbaum FR, Norton L, Graw RG, Jr: Migration of transfused granulocytes in leukopenic dogs. Blood, 1977; 49: 483–88.
Alavi JB, Root RK, Djerassi I, et al.: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med, 1977; 296: 706–11.
Sandler SG, Nusbacher J: Health risks of leukapheresis donors. Haematolgia, 1982; 15: 57–69.
Olson PR, Cox C, McCullough J: Laboratory and Clinical effects of the infusion of ACD solution during plateletpheresis. Vox Sang, 1977; 33: 79–87.
Wright DG, Karsh J, Fauci AS, Klippel JH, Deisseroth AB, Decker JL: Lymphocytapheresis. In: The Lymphocyte, Sell KW, Miller WV (eds). Alan R. Liss, Inc., New York, NY, 1981: 217–24.
Koepke JA, Parks WM, Goeken JA, Klee GG, Strauss RG: The safety of weekly plateletpheresis: Effect on the donors’ lymphocyte population. Transfusion, 1981; 21: 59–63.
Shohet SB: Morphologic evidence for the in vivo activity of transfused chronic myelogenous leukemia cells in a case of massive staphylococcal septicemia. Blood, 1968; 32: 111–18.
Price TH, Dale DC: Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method, donor corticosteroid treatment, and short-term storage. Blood, 1979; 54: 977–86.
Eyre HJ, Goldstein IM, Perry S, Graw RG, Jr: Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Blood, 1970; 36: 432–44.
Arnold R, Pflieger H, Dietrich M, Heimpel H: The clinical efficacy of granulocyte transfusions: studies on the oral cavity. Blut, 1977; 35: 405–14.
Thakur ML, Coleman RE, Welch MJ: Indium-III-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med, 1977; 89: 217–28.
Weiblen BJ, Forstrom L, McCullough J: Studies of the kinetics of indium-III-labeled granulocytes. J Lab Clin Med, 1979; 94: 246–55.
McCullough J, Weiblen BJ, Clay ME, Forstrom L: Effect of leukocyte antibodies on the fate in vivo of indium-IIIlabeled granulocytes. Blood, 1981; 58: 164–70.
Ascher NL, Ahrenholz DH, Simmons RL, Weiblen B, Gomez L, Forstrom LA, Frick MP, Henke C, McCullough J: Indium III autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis. Arch Surg, 1979; 114: 386–92.
Frick MP, Henke CE, Forstrom LA, Simmons RA, McCullough J, Loken MK: Use of 111-in-labeled leukocytes in evaluation of renal transplant rejections: A preliminary report. Clin Nucl Med, 1979; 4: 24–25.
Forstrom LA, Weiblen BJ, Gomez L, Ascher NL, Hoogland DR, Loken MK, McCullough J: Indium-111-oxine labelled leukocytes in the diagnosis of occult inflammatory disease. In: Indium-111 Labeled Neutrophils, Platelets, and Lymphocytes. Thakur ML, Gottschalk A (eds), 1979: 123–30.
Graw RG, Jr, Eyre HJ, Goldstein IM, Terasaki PI: Histocompatibility testing for leukocyte transfusion. Lancet, 1970; ii: 77–78.
Goldstein IM, Eyre HJ, Terasaki PI, Henderson ES, Graw RG, Jr: Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion, 1971; 11: 19–24.
Herzig RH, Herzig GP, Graw RG, Jr, Bull MI, Ray KK: Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med, 1977; 296: 701–5.
McCredie KB, Freireich EJ, Hester JP, Vallejos C: Leukocyte transfusion therapy for patients with host-defense failure. Transplant Proc, 1973; 5: 1285–89.
McCredie KB, Hester JP, Freireich EJ, Brittin GM, Vallejos C: Platelet and leukocyte transfusions in acute leukemia. Hum Pathol, 1974; 5: 699–708.
Underleider RS, Appelbaum FR, Trapani RJ, Deisseroth AB: Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy. Transfusion, 1979; 19: 90–94.
Westrick MA, Debelak-Fehir KM, Epstein RB: The effect of prior whole blood transfusion on subsequent granulocyte support in leukopenic dogs. Transfusion, 1977; 17: 611–14.
Appelbaum FR, Trapani RJ, Graw RG: Consequences of prior alloimmunization during granulocyte transfusion. Transfusion, 1977; 17: 460–64.
Chow HS, Alexander DL, Epstein RB: Detection and significance of granulocyte alloimmunization in leukocyte transfusion therapy on neutropenic dogs. Transfusion 1983; 23: 45–48.
Dahlke MB, Keashen M, Alavi JB, Koch PA, Eisenstaedt R: Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsis. Transfusion, 1982; 22: 374–78.
Dutcher JP, Schiffer CA, Johnston GS, Papenberg D, Daly PA, Aisner J, Wiernik PH: The effect of histocompatibility factors on the migration of transfused 111indium-labeled granulocytes. Blood, 1982; 58: 181a (abstract).
Dutcher JP, Fox JJ, Riggs C, Johnston GS, Schiffer CA: Pulmonary retention of indium-III-labeled granulocytes in alloimmunized patients. Blood, 1982; 58: 171a (abstract).
McCullough J, Clay M, Richards K, Forstrom L, Loken M: Leukocyte antibodies: Their effect on the fate in vivo of indium-111-labeled granulocytes. Blood, 1982; 60: 80a (abstract).
McCullough J: Liquid preservation of granulocytes. Transfusion, 1980; 20: 129–37.
Glasser L: Effect of storage on normal neutrophils collected by discontinuous-flow centrifugation leukapheresis. Blood, 1977; 50: 1145–50.
McCullough J, Weiblen BJ, Peterson PK, Quie PG: Effects of temperature on granulocyte preservation. Blood, 1978; 52: 301–19.
Palm SL, Furcht LT, McCullough J: Effects of temperature and duration of storage on granulocyte adhesion, spreading, and ultrastructure. Lab Invest, 1981; 45: 82–88.
Price TH, Dale DC: Neutrophil preservation. The effect of short-term storage on in vivo kinetics. J Clin Invest, 1977; 59: 475–80.
Price TH, Dale DC: Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short-term storage. Blood, 1979; 54: 977–86.
McCullough J, Weiblen BJ, Fine D: Effects of storage of granulocytes on their fate in vivo. Transfusion, 1983; 23: 20–24.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers. Boston/Dordrecht/Lancaster
About this chapter
Cite this chapter
McCullough, J. (1985). Leukapheresis: clinical experience and post-transfusion control. In: Das, P.C., Sibinga, C.T.S., Halie, M.R. (eds) Supportive therapy in haematology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2577-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2577-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9617-1
Online ISBN: 978-1-4613-2577-2
eBook Packages: Springer Book Archive